tuneTypical Dose
250-500 mg DHA+EPA daily for general health, or 1,000-2,000 mg for therapeutic goals
Fatty Acid
Algal oil (Schizochytrium sp. / Ulkenia sp. DHA+EPA)
tuneTypical Dose
250-500 mg DHA+EPA daily for general health, or 1,000-2,000 mg for therapeutic goals
watchEffect Window
4-12 weeks for omega-3 index optimization
check_circleCompliance
WADA NOT PROHIBITED
Overview
Algal oil is a vegan source of DHA and sometimes EPA produced from microalgae. It is used to raise omega-3 status for brain, eye, and triglyceride-related outcomes without fish-derived oils.
Trials show algal oil effectively raises blood DHA and EPA levels and can modestly lower triglycerides. It supports pregnancy and lactation omega-3 needs without marine allergens. Minority evidence suggests modest anti-inflammatory effects and potential eye health benefits similar to fish oil. Benefits depend on achieving sufficient EPA plus DHA intake, since many algal products are DHA dominant.
Provides pre-formed EPA and DHA from microalgae, bypassing the inefficient ALA conversion pathway (<5%). EPA/DHA incorporate into cell membranes and modulate eicosanoid pathways.
Outcomes
Safety
Evidence
Arterburn LM, et al. *Algal-oil capsules and cooked salmon: nutritionally equivalent sources of docosahexaenoic acid.* J Am Diet Assoc. 2008.
Population: Healthy adults (N=32)
Dose protocol: Algal DHA capsules vs cooked salmon (equivalent DHA), crossover with washout
Key findings: Algal DHA capsules and cooked salmon produced equivalent increases in plasma and erythrocyte DHA, establishing bioequivalence for the primary delivery endpoint.
Notes: Foundational bioequivalence study. Single DHA source comparison (EPA not isolated).
Algal DHA capsules and cooked salmon produced equivalent increases in plasma and erythrocyte DHA, establishing bioequivalence for the primary delivery endpoint.
Ryan L, Symington AM. *Algal-oil supplements are a viable alternative to fish-oil supplements in terms of docosahexaenoic acid.* J Funct Foods. 2015.
Population: Healthy adults
Dose protocol: Algal DHA supplementation vs fish oil, 4-week intervention
Key findings: Algal oil increased DHA status comparably to fish oil over the intervention period and confirmed as a viable plant-based alternative.
Notes: Short duration. Consistent with Arterburn 2008 findings.
Algal oil increased DHA status comparably to fish oil over the intervention period; confirmed as a viable plant-based alternative.
Sarter B, et al. *Blood docosahexaenoic acid and eicosapentaenoic acid in vegans: Associations with age and gender and effects of an algal-derived omega-3 fatty acid supplement.* Clin Nutr. 2015.
Population: Vegans (N=165 observational; subset supplemented)
Dose protocol: Algal omega-3 supplementation in vegans with low baseline omega-3 status
Key findings: Vegans have significantly lower EPA and DHA levels than omnivores. Algal supplementation effectively raised omega-3 status. Age and gender influenced baseline levels.
Notes: Demonstrates the need for supplementation in vegan populations and confirms algal efficacy for correcting deficiency.
Vegans have significantly lower EPA and DHA levels than omnivores; algal supplementation effectively raised omega-3 status. Age and gender influenced baseline levels.
Yang Y, Li G, Li F, et al. Impact of DHA from Algal Oil on the Breast Milk DHA Levels of Lactating Women: A Randomized Controlled Trial in China. Nutrients. 2022;14:3410. doi:10.3390/nu14163410. PMID:36014916.
Population: Healthy lactating women 30 to 50 days postpartum in Nanjing, China.
Dose protocol: 200 mg DHA/day from algal oil for 8 weeks in lactating women
Key findings: Algal DHA supplementation significantly increased breast milk DHA levels (10.07 vs 7.57 mg/100 mL). Control group DHA declined over the study period.
Notes: Supports algal oil use during lactation for infant omega-3 provision.
This RCT tested 200 mg/day DHA from algal oil for 8 weeks in 160 lactating women in China. The supplemented group achieved significantly higher absolute and relative breast milk DHA concentrations compared to controls, whose DHA levels actually declined over the study period. Dietary patterns influenced the magnitude of the effect, with cereal and bean-dominant diets attenuating the intervention response. The study demonstrates that algal-derived DHA is effective for improving breast milk omega-3 content, which is relevant for infant neurodevelopment in populations with low fish intake.
Chamorro R, Tabilo C, Munoz Y, et al. Vegetarian Diets and Their Effect on n-3 Polyunsaturated Fatty Acids Status in Humans: Systematic Review. Lipids. 2026;61(1):29-53. doi:10.1002/lipd.70009. PMID:40958088.
Population: Humans across various life stages following vegetarian or vegan diets, with emphasis on pregnancy and growth periods.
Dose protocol: Systematic review of 45 studies on vegetarian diets and n-3 PUFA status
Key findings: Vegetarian and vegan diets significantly reduce EPA and DHA concentrations. Microalgae oil supplementation effectively improved serum DHA status during pregnancy and lactation.
Notes: Reinforces the rationale for algal omega-3 supplementation across the vegetarian population.
This systematic review of 45 studies examined the impact of vegetarian and vegan diets on omega-3 polyunsaturated fatty acid status. The review confirmed that vegetarian diets increase linoleic acid and ALA intake but significantly reduce EPA and DHA concentrations, particularly in vegans. Microalgae oil supplementation effectively improved serum DHA status during pregnancy and lactation. The authors emphasize the need for strict dietary planning and supplementation strategies for vegetarians, especially during critical developmental periods. This reinforces the rationale for algal omega-3 supplementation in plant-based populations.